FDA Revises Equivalence Criteria For Generic Drug Approval
The U.S. Food and Drug Administration on Wednesday revised its recommendations for how generic-drug makers can prove that their products are released into the human body in the same manner as...To view the full article, register now.
Already a subscriber? Click here to view full article